These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15885939

  • 1. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB, Na DH, Thanoo BC, DeLuca PP.
    Int J Pharm; 2005 Jun 13; 297(1-2):62-72. PubMed ID: 15885939
    [Abstract] [Full Text] [Related]

  • 2. Impurity formation studies with peptide-loaded polymeric microspheres Part I. In vivo evaluation.
    Murty SB, Thanoo BC, Wei Q, DeLuca PP.
    Int J Pharm; 2005 Jun 13; 297(1-2):50-61. PubMed ID: 15893894
    [Abstract] [Full Text] [Related]

  • 3. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB, Goodman J, Thanoo BC, DeLuca PP.
    AAPS PharmSciTech; 2003 Oct 13; 4(4):E50. PubMed ID: 15198545
    [Abstract] [Full Text] [Related]

  • 4. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH, DeLuca PP.
    Pharm Res; 2005 May 13; 22(5):736-42. PubMed ID: 15906168
    [Abstract] [Full Text] [Related]

  • 5. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE.
    Pharm Res; 2012 Jan 13; 29(1):110-20. PubMed ID: 21744173
    [Abstract] [Full Text] [Related]

  • 6. Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.
    Na DH, Murty SB, Lee KC, Thanoo BC, DeLuca PP.
    AAPS PharmSciTech; 2003 Dec 31; 4(4):E72. PubMed ID: 15198567
    [Abstract] [Full Text] [Related]

  • 7. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.
    Vaishya RD, Mandal A, Patel S, Mitra AK.
    Int J Pharm; 2015 Dec 30; 496(2):676-88. PubMed ID: 26561725
    [Abstract] [Full Text] [Related]

  • 8. Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres.
    Liang R, Li X, Shi Y, Wang A, Sun K, Liu W, Li Y.
    Int J Pharm; 2013 Sep 15; 454(1):344-53. PubMed ID: 23872225
    [Abstract] [Full Text] [Related]

  • 9. Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.
    Ahn JH, Park EJ, Lee HS, Lee KC, Na DH.
    AAPS PharmSciTech; 2011 Dec 15; 12(4):1220-6. PubMed ID: 21935743
    [Abstract] [Full Text] [Related]

  • 10. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M, Hennink WE, Somsen GW, van Nostrum CF.
    Pharm Res; 2015 Sep 15; 32(9):3044-54. PubMed ID: 25832500
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M, Najafi M, Rijkers DT, Kok RJ, Hennink WE, van Nostrum CF.
    Bioconjug Chem; 2016 Mar 16; 27(3):576-85. PubMed ID: 26726953
    [Abstract] [Full Text] [Related]

  • 12. Peptide acylation by poly(alpha-hydroxy esters).
    Lucke A, Kiermaier J, Göpferich A.
    Pharm Res; 2002 Feb 16; 19(2):175-81. PubMed ID: 11883645
    [Abstract] [Full Text] [Related]

  • 13. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP.
    Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463
    [Abstract] [Full Text] [Related]

  • 14. Minimizing acylation of peptides in PLGA microspheres.
    Zhang Y, Schwendeman SP.
    J Control Release; 2012 Aug 20; 162(1):119-26. PubMed ID: 22546683
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 20; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 16. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.
    Na DH, Lee JE, Jang SW, Lee KC.
    AAPS PharmSciTech; 2007 Jun 08; 8(2):Article 43. PubMed ID: 17622118
    [Abstract] [Full Text] [Related]

  • 17. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S, Janoria KG, Mitra AK.
    J Control Release; 2005 Nov 28; 108(2-3):282-93. PubMed ID: 16229919
    [Abstract] [Full Text] [Related]

  • 18. Separation and identification of acylated leuprorelin inside PLGA microspheres.
    Guo N, Zhang Q, Sun Y, Yang H.
    Int J Pharm; 2019 Apr 05; 560():273-281. PubMed ID: 30731258
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.
    Na DH, Youn YS, Lee SD, Son MW, Kim WB, DeLuca PP, Lee KC.
    J Control Release; 2003 Oct 30; 92(3):291-9. PubMed ID: 14568410
    [Abstract] [Full Text] [Related]

  • 20. Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.
    Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK.
    Int J Pharm; 2015 Jul 15; 489(1-2):237-45. PubMed ID: 25940041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.